secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K/A
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001213900-22-034884
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics reports annual meeting results; all director nominees elected, auditor ratified
--------------------------------------------------------------------------------

- All five director nominees elected: Tiago Reis Marques (5.79M for, 2.07M withheld), Yassine Bendiabdallah, Lawrence Steinman, Simon Dumesnil, Emer Leahy.
- Ratification of Marcum LLP as auditor for FY2022 approved with 10.75M for, 1.08M against, 15.6K abstain.
- Broker non-votes totaled 3.98M on director elections; no broker non-votes on auditor ratification.
- Shareholders present at meeting represented 22.86M shares outstanding as of May 3, 2022 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022034884/0001213900-22-034884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022034884/ea162049-8ka_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-034884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer